• Postural tachycardia syndrome and long COVID: an update – “There is a growing concern that, in addition to long COVID, we may now also be facing an epidemic of PoTS.12 There has never been a greater need to invest in NHS services to serve the unmet needs of this population. Perhaps we can learn from the rapid development of multidisciplinary teams in long COVID clinics and utilise these new skills and resources in the long term to also provide long overdue equitable access to therapeutic pathways for all patients with PoTS.”
  • Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection – “In summary, POTS-related diagnoses appear to be acquired with increased frequency after, compared to before, COVID-19 vaccination, particularly when compared to more commonly diagnosed conditions, but at a rate that is approximately five times lower than after SARS-CoV-2 infection. Additional research regarding the relation between COVID-19 vaccination and POTS is needed. By further developing the evidence base and augmenting understanding around emerging vaccine side effects, clinical researchers may work to enhance medical trust and improve quality of care as well as communications around vaccines, with the ultimate goal of optimizing vaccine uptake.”
  • Long-Haul COVID Patients: Prevalence of POTS Are Reduced but Cerebral Blood Flow Abnormalities Remain Abnormal with Longer Disease Duration – “In long-haul COVID-19 patients with orthostatic intolerance complaints, the hemodynamic abnormalities change over time after the onset of symptoms. Patients studied early after the onset of the disease mainly exhibited POTS during the tilt test, but patients studied later in the time course of the disease showed OH or had a normal heart rate and blood pressure response during the tilt. This suggests that the hemodynamic abnormalities in individual patients may change over time. If confirmed in serial follow-up tilt test studies in these patients, patient management may need to be changed over time. In addition, the objective abnormalities of the orthostatic intolerance, cerebral blood flow measurements, show a reduction in the degree of abnormalities. However, the improvement is modest, and patients still have orthostatic intolerance. Whether this pattern of further improvement is sustained, and results in reduction of orthostatic intolerance complaints, needs to be studied in the future.”